Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Virax Biolabs Group stock

Learn how to buy Virax Biolabs Group stock in 5 easy steps.

Virax Biolabs Group is a biotechnology business based in the US. Virax Biolabs Group shares (VRAX) are listed on the NASDAQ and all prices are listed in US Dollars. Virax Biolabs Group employs 5 staff and has a trailing 12-month revenue of around $5,760.

How to buy Virax Biolabs Group stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – VRAX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Virax Biolabs Group stock price (NASDAQ: VRAX)

Use our graph to track the performance of VRAX stocks over time.

Virax Biolabs Group shares at a glance

Information last updated 2023-03-23.
Latest market close$0.70
52-week range$0.54 - $29.00
50-day moving average $0.79
200-day moving average $2.78
Wall St. target priceN/A
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.21

Buy Virax Biolabs Group stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $10,000 - $250,000+
Stocks, Bonds, Options, Mutual funds, ETFs, Futures
Get up to $600 or more
when you open and fund a new account.
E*TRADE offers commission-free stocks, access to mutual funds and advanced trading tools. Other fees apply.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Virax Biolabs Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Virax Biolabs Group price performance over time

Historical closes compared with the close of $0.7012 from 2023-03-24

1 week (2023-03-17) 0.11%
1 month (2023-02-24) 9.22%
3 months (2022-12-23) 23.02%
6 months (2022-09-26) -76.93%
1 year (2022-03-22) N/A
2 years (2021-03-22) N/A
3 years (2020-03-22) N/A
5 years (2018-03-22) N/A

Virax Biolabs Group financials

Revenue TTM $5,760
Gross profit TTM $-9,434
Return on assets TTM -61.02%
Return on equity TTM -166.71%
Profit margin 0%
Book value $0.38
Market capitalisation $9.6 million

TTM: trailing 12 months

Virax Biolabs Group share dividends

We're not expecting Virax Biolabs Group to pay a dividend over the next 12 months.

Virax Biolabs Group overview

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, individual consumers, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021.

Frequently asked questions

What percentage of Virax Biolabs Group is owned by insiders or institutions?
Currently 54.772% of Virax Biolabs Group shares are held by insiders and 1.484% by institutions.
How many people work for Virax Biolabs Group?
Latest data suggests 5 work at Virax Biolabs Group.
When does the fiscal year end for Virax Biolabs Group?
Virax Biolabs Group's fiscal year ends in March.
Where is Virax Biolabs Group based?
Virax Biolabs Group's address is: 30 Broadwick Street, London, United Kingdom, W1F 8LX

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site